Litigation Details for TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC (D.N.J. 2019)

TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC (D.N.J. 2019)

Docket		Date Filed	2019-01-24
Court	District Court, D. New Jersey	Date Terminated	2020-06-29
Cause	35:271 Patent Infringement	Assigned To	Freda L. Wolfson
Jury Demand	None	Referred To	Lois H. Goodman
Patents	7,560,445; 7,977,324
Link to Docket	External link to docket

Details for TARO PHARMACEUTICAL INDUSTRIES LTD. v. NOVITIUM PHARMA, LLC (D.N.J. 2019)

Date Filed	Document No.	Description	Snippet	Link To Document
2019-01-24	1		for patent infringement of United States Patent No. 7,560,445 (“the ’445 patent”) and U.S. Patent No.…Attachments: # 1 Exhibit A - '445 Patent, # 2 Exhibit B - '324 Patent, # 3 Civil Cover Sheet, # 4 FORM …No. 7,977,324 (“the ’324 patent”) under the Patent Laws of the United States, 35 U.S.C. § 1 et seq., including… ’445 patent, entitled “Process for Preparing Malathion for Pharmaceutical Use.” The ’445 patent was duly…’324 patent, entitled “Process for Preparing Malathion for Pharmaceutical Use.” The ’324 patent was duly	External link to document
2020-04-06	63	Opinion	are four patents owned by Taro which share a common specification: U.S. Patent Nos. 7,560,445 (“the ’455… 1 patent”), and 8,536,155 (“the ’155 patent”) (collectively, the “patents-in-suit”). Pls.…53 of the ’445 patent, Claims 20, and 31 of the ’324 patent, Claim 28 of the ’657 patent, and Claim 18…’455 patent”), 7,977,324 (“the ’324 patent”), 8,039,657 (“the ’657 …445 Patent at 2:58-3:3. Taro currently markets formulations utilizing embodiments of the patents-in-suit	External link to document